Suptavumab, CAS 1629615-23-1

Product Description: Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab can bind and block a conserved epitope on RSV A and B subtypes. Suptavumab can be used for the research of RSV infection[1][2].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Simões EAF, et al. Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants. Clin Infect Dis. 2021 Dec 6;73(11):e4400-e4408. /[2]Rodriguez-Fernandez R, et al. Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Infection. Pediatr Infect Dis J. 2021 May 1;40(5S):S35-S39.

CAS Number: 1629615-23-1

Molecular Weight: N/A

Compound Purity: 95.0

Research Area: Infection

Solubility: 10 mM in DMSO

Target: RSV

• Artikelnummer: MEXHY-P99586-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99586-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated